Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vietnam | 14 | 2021 | 1665 | 0.97 | Why? |
| Tetanus | 2 | 2018 | 61 | 0.84 | Why? |
| Hand, Foot and Mouth Disease | 2 | 2018 | 115 | 0.83 | Why? |
| Enterovirus A, Human | 2 | 2018 | 180 | 0.77 | Why? |
| Angiostrongylus cantonensis | 1 | 2017 | 6 | 0.72 | Why? |
| Strongylida Infections | 1 | 2017 | 6 | 0.72 | Why? |
| Cichlids | 1 | 2017 | 5 | 0.71 | Why? |
| Arsenic | 1 | 2017 | 85 | 0.64 | Why? |
| Lead | 1 | 2017 | 94 | 0.64 | Why? |
| Meningitis | 1 | 2017 | 163 | 0.59 | Why? |
| Enterovirus Infections | 2 | 2018 | 404 | 0.56 | Why? |
| Developmental Disabilities | 1 | 2017 | 257 | 0.53 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.53 | Why? |
| Water Pollutants, Chemical | 1 | 2017 | 410 | 0.44 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.32 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.31 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.24 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.19 | Why? |
| Flaviviridae Infections | 1 | 2018 | 27 | 0.19 | Why? |
| Flaviviridae | 1 | 2018 | 60 | 0.19 | Why? |
| Injections, Spinal | 1 | 2018 | 61 | 0.18 | Why? |
| Metagenome | 1 | 2020 | 268 | 0.18 | Why? |
| Gills | 1 | 2017 | 10 | 0.18 | Why? |
| Genome, Viral | 3 | 2020 | 13157 | 0.18 | Why? |
| Coxsackievirus Infections | 1 | 2018 | 71 | 0.18 | Why? |
| Metagenomics | 2 | 2020 | 823 | 0.17 | Why? |
| Muscles | 1 | 2017 | 152 | 0.16 | Why? |
| Text Messaging | 1 | 2021 | 389 | 0.15 | Why? |
| Central Nervous System Infections | 1 | 2017 | 158 | 0.15 | Why? |
| Emigration and Immigration | 1 | 2021 | 501 | 0.15 | Why? |
| Metals, Heavy | 1 | 2017 | 147 | 0.15 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.12 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.12 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.12 | Why? |
| Intensive Care Units, Neonatal | 1 | 2017 | 749 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.11 | Why? |
| Tertiary Care Centers | 2 | 2020 | 8248 | 0.11 | Why? |
| Mass Screening | 2 | 2021 | 8005 | 0.11 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.10 | Why? |
| Health Education | 1 | 2021 | 1539 | 0.10 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.10 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.10 | Why? |
| Phylogeny | 4 | 2020 | 13341 | 0.09 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.09 | Why? |
| Public Policy | 1 | 2021 | 1894 | 0.09 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.08 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.08 | Why? |
| Child, Preschool | 3 | 2018 | 36283 | 0.07 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.07 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.07 | Why? |
| Child | 6 | 2021 | 70012 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.07 | Why? |
| Dengue | 1 | 2017 | 1565 | 0.07 | Why? |
| Animals | 3 | 2020 | 78931 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.06 | Why? |
| Humans | 18 | 2021 | 930598 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Male | 10 | 2021 | 367725 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.06 | Why? |
| Travel | 1 | 2021 | 7220 | 0.06 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.05 | Why? |
| Multiplex Polymerase Chain Reaction | 2 | 2018 | 1439 | 0.05 | Why? |
| Female | 7 | 2021 | 380317 | 0.05 | Why? |
| Adult | 8 | 2021 | 244371 | 0.05 | Why? |
| Tetanus Antitoxin | 1 | 2018 | 5 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Infant | 2 | 2018 | 30274 | 0.05 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.05 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.05 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
| Cambodia | 1 | 2017 | 190 | 0.04 | Why? |
| Encephalitis Virus, Japanese | 1 | 2017 | 63 | 0.04 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Crowding | 1 | 2020 | 731 | 0.03 | Why? |
| Child, Hospitalized | 1 | 2017 | 556 | 0.03 | Why? |
| Enterovirus | 1 | 2017 | 402 | 0.03 | Why? |
| Phylogeography | 1 | 2018 | 824 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.03 | Why? |
| Demography | 1 | 2018 | 1660 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2021 | 3120 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 13720 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Tan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(112)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_